Viewing Study NCT05656027


Ignite Creation Date: 2025-12-25 @ 5:09 AM
Ignite Modification Date: 2025-12-26 @ 4:14 AM
Study NCT ID: NCT05656027
Status: COMPLETED
Last Update Posted: 2024-12-18
First Post: 2022-12-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase 3 Evaluation of the Safety and Efficacy of LNZ101 for the Treatment of Presbyopia
Sponsor: LENZ Therapeutics, Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module